Cardiovascular Clinical Research Facility, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Headley Way, Headington, Oxford OX3 9DU, UK.
Department of Biomedical and Molecular Sciences, Queens University, Barrie St, Kingston, Canada.
Eur J Prev Cardiol. 2024 Jan 5;31(1):77-99. doi: 10.1093/eurjpc/zwad275.
Hypertensive pregnancy is associated with increased risks of developing a range of vascular disorders in later life. Understanding when hypertensive target organ damage first emerges could guide optimal timing of preventive interventions. This review identifies evidence of hypertensive target organ damage across cardiac, vascular, cerebral, and renal systems at different time points from pregnancy to postpartum.
Systematic review of Ovid/MEDLINE, EMBASE, and ClinicalTrials.gov up to and including February 2023 including review of reference lists. Identified articles underwent evaluation via a synthesis without meta-analysis using a vote-counting approach based on direction of effect, regardless of statistical significance. Risk of bias was assessed for each outcome domain, and only higher quality studies were used for final analysis. From 7644 articles, 76 studies, including data from 1 742 698 pregnancies, were identified of high quality that reported either blood pressure trajectories or target organ damage during or after a hypertensive pregnancy. Left ventricular hypertrophy, white matter lesions, proteinuria, and retinal microvasculature changes were first evident in women during a hypertensive pregnancy. Cardiac, cerebral, and retinal changes were also reported in studies performed during the early and late post-partum period despite reduction in blood pressure early postpartum. Cognitive dysfunction was first reported late postpartum.
The majority of target organ damage reported during a hypertensive pregnancy remains evident throughout the early and late post-partum period despite variation in blood pressure. Early peri-partum strategies may be required to prevent or reverse target organ damage in women who have had a hypertensive pregnancy.
妊娠高血压与多种血管疾病在生命后期的发生风险增加有关。了解高血压靶器官损伤何时首次出现,有助于指导最佳预防干预时机。本综述确定了从妊娠到产后不同时间点心脏、血管、大脑和肾脏系统中高血压靶器官损伤的证据。
对 Ovid/MEDLINE、EMBASE 和 ClinicalTrials.gov 进行系统回顾,检索时间截至 2023 年 2 月,包括对参考文献的回顾。通过一种不进行荟萃分析的综合方法,根据效应方向对确定的文章进行评估,无论统计意义如何。对每个结局领域的偏倚风险进行评估,仅使用高质量的研究进行最终分析。从 7644 篇文章中,确定了 76 项高质量研究,这些研究共纳入了 1742698 例妊娠的数据,报告了高血压妊娠期间或之后的血压轨迹或靶器官损伤。左心室肥厚、白质病变、蛋白尿和视网膜微血管变化首先在高血压妊娠期间的女性中出现。尽管产后早期血压下降,但在产后早期和晚期进行的研究中也报告了心脏、大脑和视网膜的变化。认知功能障碍首先在产后晚期报告。
尽管血压存在差异,但在高血压妊娠期间报告的大多数靶器官损伤在整个早期和晚期产后期间仍然存在。可能需要在围产期早期采取策略来预防或逆转有高血压妊娠史的女性的靶器官损伤。